AU2649977A - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
AU2649977A
AU2649977A AU26499/77A AU2649977A AU2649977A AU 2649977 A AU2649977 A AU 2649977A AU 26499/77 A AU26499/77 A AU 26499/77A AU 2649977 A AU2649977 A AU 2649977A AU 2649977 A AU2649977 A AU 2649977A
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU26499/77A
Inventor
Lawrence Flora
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of AU2649977A publication Critical patent/AU2649977A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
AU26499/77A 1976-07-15 1977-06-27 Pharmaceutical composition Pending AU2649977A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70565076A 1976-07-15 1976-07-15

Publications (1)

Publication Number Publication Date
AU2649977A true AU2649977A (en) 1979-01-04

Family

ID=24834378

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26499/77A Pending AU2649977A (en) 1976-07-15 1977-06-27 Pharmaceutical composition

Country Status (9)

Country Link
JP (1) JPS5334930A (en)
AU (1) AU2649977A (en)
BE (1) BE856849A (en)
CA (1) CA1100874A (en)
DE (1) DE2731366A1 (en)
FR (1) FR2358153A1 (en)
GB (1) GB1582694A (en)
NL (1) NL7707849A (en)
NZ (1) NZ184496A (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59117882A (en) * 1982-12-25 1984-07-07 Kazuo Hashimoto Door scope
JPS59148479A (en) * 1983-02-14 1984-08-25 Aihon Kk Television and interphone system for multiple dwelling house
JPS6139788A (en) * 1984-07-31 1986-02-25 Toshiba Electric Equip Corp Interphone system of multiple dwelling house
JPH0822059B2 (en) * 1985-02-07 1996-03-04 アイホン株式会社 Video intercom
JPS63234792A (en) * 1987-03-24 1988-09-30 Izumi Soken Eng:Kk Unmanned information desk guiding system
US5139786A (en) * 1989-07-07 1992-08-18 Ciba-Geigy Corporation Topical formulations
MX21452A (en) * 1989-07-07 1994-01-31 Ciba Geigy Ag PHARMACEUTICAL PREPARATIONS THAT ARE TOPICALLY ADMINISTERED.
CN1633300A (en) 2002-02-14 2005-06-29 山之内制药株式会社 Percutaneous preparations
CN101511371A (en) 2006-09-11 2009-08-19 救急药品工业株式会社 Adhesive preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH9853A (en) * 1972-06-08 1976-04-13 M Francis Compositions for inhibiting mobilization of calcium phosphate in animal tissue and method of use thereof

Also Published As

Publication number Publication date
GB1582694A (en) 1981-01-14
DE2731366A1 (en) 1978-01-19
FR2358153A1 (en) 1978-02-10
CA1100874A (en) 1981-05-12
JPS5334930A (en) 1978-03-31
NL7707849A (en) 1978-01-17
BE856849A (en) 1978-01-16
FR2358153B1 (en) 1979-05-11
NZ184496A (en) 1980-08-26

Similar Documents

Publication Publication Date Title
JPS52143218A (en) Pharmaceutical composition
JPS52113976A (en) Pharmaceutical composition
ZA774920B (en) Pharmaceutical compositions
JPS5362838A (en) Pharmaceutical composition
AU515341B2 (en) Pharmaceutical composition
PT66622A (en) Pharmaceutical compositions
JPS5372814A (en) Pharmaceutical composition
JPS52102432A (en) Pharmaceutical composition containing pyretrinoid
AU3152677A (en) Pharmaceutical composition
NZ186147A (en) Sterolin pharmaceutical compositions
NZ184539A (en) 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine pharmaceutical compositions
AU2609277A (en) Pharmaceutical compositions
JPS5356634A (en) Pharmaceutical composition
AU2649977A (en) Pharmaceutical composition
AU508191B2 (en) Pharmaceutical composition
PT66509A (en) Pharmaceutical compositions
GB1547206A (en) Pharmaceutical compositions
AU2574877A (en) Pharmaceutical compositions
JPS5283918A (en) Pharmaceutical composition
HK3984A (en) Pharmaceutical compositions
NZ183436A (en) Substituted phenylguanidines and pharmaceutical compositions
ZA771408B (en) Pharmaceutical compositions
JPS52122633A (en) Pharmaceutical composition
ZA777335B (en) Pharmaceutical compounds
PT66465B (en) Pharmaceutical composition